This brand name is authorized in Nigeria.
The drug SULPHATRIAD contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
Y7FKS2XWQH - SULFATHIAZOLE
|
2
|
UNII
0N7609K889 - SULFADIAZINE
|
|
Sulfadiazine is an antibiotic that belongs to the class of drugs known as sulphonamides. Sulfadiazine is a structural analogue and competitive antagonist of p-aminobenzoic acid preventing bacterial utilisation of PABA in the synthesis of folic acid. |
|
3
|
Sulfamerazine
UNII
UR1SAB295F - SULFAMERAZINE
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-0322 | Tablet | Sulphatriad Tablets TAB 185 mg; 185 mg; 130 mg 1 x 500's (in jar) | Tablet | 29/03/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A07AB | Sulfonamides | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-0322 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.